| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/13/2023 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 74.6k | $0.00 | $0 | | 06/13/2023 |
| 08/12/2022 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 5k | $17.25 | $86.2k | | 08/11/2022 |
| 08/12/2022 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 5k | $17.25 | $86.2k | | 08/11/2022 |
| 08/11/2022 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 10k | $16.50 | $165k | | 08/11/2022 |
| 08/11/2022 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 10k | $16.50 | $165k | | 08/11/2022 |
| 06/22/2022 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 10k | $11.76 | $117.6k | | 06/22/2022 |
| 06/15/2022 | Allogene Therapeutics, Inc. | ALLO | Grant | Stock Option (Right to Buy) | 35.5k | $9.62 | $341.8k | | 06/15/2022 |
| 06/15/2022 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 22.1k | $0.00 | $0 | | 06/15/2022 |
| 09/09/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 5k | $25.54 | $127.7k | | 09/09/2021 |
| 08/20/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 5k | $23.24 | $116.2k | | 08/20/2021 |
| 08/20/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 5k | $23.70 | $118.5k | | 08/20/2021 |
| 06/10/2021 | Allogene Therapeutics, Inc. | ALLO | Grant | Stock Option (Right to Buy) | 28k | $25.76 | $721.7k | | 06/09/2021 |
| 06/09/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 10k | $25.05 | $249.7k | | 06/09/2021 |
| 06/05/2020 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 10k | $0.00 | $0 | | 06/05/2020 |
| 06/06/2019 | Allogene Therapeutics, Inc. | ALLO | Grant | Stock Option (Right to Buy) | 26k | $25.95 | $675.3k | | 06/06/2019 |
| 10/15/2018 | Allogene Therapeutics, Inc. | ALLO | Conversion | Series A Convertible Preferred Stock | 7.1k | $0.00 | $0 | | 10/15/2018 |
| 10/15/2018 | Allogene Therapeutics, Inc. | ALLO | Conversion | Common Stock | 37.4k | $0.00 | $0 | | 10/15/2018 |
| 10/15/2018 | Allogene Therapeutics, Inc. | ALLO | Purchase | Common Stock | 15k | $18.00 | $270k | | 10/15/2018 |
| 06/26/2017 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 12.5k | $100.60 | $1.3M | | 06/23/2017 |
| 06/23/2017 | Kite Pharma, Inc. | KITE | Exercise | Employee Stock Option (Right to Buy) | 10k | $6.89 | $68.9k | | 06/23/2017 |
| 06/23/2017 | Kite Pharma, Inc. | KITE | Sale | Common Stock | 12.5k | $100.00 | $1.2M | | 06/23/2017 |
| 06/23/2017 | Kite Pharma, Inc. | KITE | Exercise | Employee Stock Option | 2.5k | $62.44 | $156.1k | | 06/23/2017 |